Combination therapy with antibody-drug conjugates
US8263083B2 · kind B2 · utility
19Cited by
6References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2008 |
| Grant date | Sep 11, 2012 |
| Priority date | — |
| Expiry date | Mar 31, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for the treatment of Hodgkin's lymphoma comprising administering both a chemotherapeutic regimen and an antibody-drug conjugate compound to a subject in need thereof are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.